Publications
Detailed Information
External Validation of a Pharmacokinetic-Pharmacodynamic Model of Propofol for Target-Controlled Infusion in Children Under Two Years of Age : 2세 미만의 소아에서 프로포폴의 목표농도조절주입을 위한 약동학-약력학 모형의 외적 타당도 평가
DC Field | Value | Language |
---|---|---|
dc.contributor.advisor | 김희수 | - |
dc.contributor.author | 지상환 | - |
dc.date.accessioned | 2018-05-29T04:54:09Z | - |
dc.date.available | 2018-05-29T04:54:09Z | - |
dc.date.issued | 2018-02 | - |
dc.identifier.other | 000000149832 | - |
dc.identifier.uri | https://hdl.handle.net/10371/142328 | - |
dc.description | 학위논문 (석사)-- 서울대학교 대학원 : 의과대학 의학과, 2018. 2. 김희수. | - |
dc.description.abstract | Background: Previously, a linked pharmacokinetic-pharmacodynamic model (Kim model) of propofol was developed for children aged 2 to 12 years, allowing target-controlled infusion. Despite an increasing need for intravenous anesthesia using propofol during surgery in children younger than two years of age, no pharmacokinetic-pharmacodynamic model of propofol has been developed for this population. Therefore, in this study, we performed an external validation of Kims propofol model for children aged less than two years.
Methods: Twenty-four children below the age of two years undergoing neurosurgery were enrolled. Anesthetic induction was commenced using a target-controlled infusion of 2% propofol based on Kim model and continuous infusion of remifentanil under bispectral index (BIS) monitoring. The target effect-site concentration of propofol was set to 2, 3, 4, and 5 g/ml, each followed by arterial blood sampling after 10 min of equilibrium. Population estimates of pooled bias, inaccuracy, divergence, and wobble were calculated to evaluate the performance of the Kim model. Results: A total of 95 plasma concentrations and 91 BIS values were used for evaluation of the Kim model. For plasma concentration of propofol, the bias was -0.96% and inaccuracy was 21.0%. For BIS, the bias was -7.7% and inaccuracy was 20.6%. Conclusions: The pooled bias and inaccuracies from the pharmacokinetic-pharmacodynamic predictions were within clinically acceptable range. Therefore, the Kim model may be applicable for propofol target-controlled infusion in children under two years of age. | - |
dc.description.tableofcontents | 1. Introduction 1
2. Methods 2 2.1 Ethics approval 2 2.2 Study population 2 2.3 Study protocol 2 2.4 Measurement of plasma concentration of propofol 4 2.5 Calculation of predicted BIS 5 2.6 External validation 5 3. Results 8 4. Discussions 10 5. References 13 | - |
dc.format | application/pdf | - |
dc.format.extent | 548461 bytes | - |
dc.format.medium | application/pdf | - |
dc.language.iso | en | - |
dc.publisher | 서울대학교 대학원 | - |
dc.subject | intravenous anesthesia | - |
dc.subject | propofol | - |
dc.subject | pharmacokinetics | - |
dc.subject | pharmacodynamics | - |
dc.subject.ddc | 610 | - |
dc.title | External Validation of a Pharmacokinetic-Pharmacodynamic Model of Propofol for Target-Controlled Infusion in Children Under Two Years of Age | - |
dc.title.alternative | 2세 미만의 소아에서 프로포폴의 목표농도조절주입을 위한 약동학-약력학 모형의 외적 타당도 평가 | - |
dc.type | Thesis | - |
dc.contributor.AlternativeAuthor | Sang-Hwan Ji | - |
dc.description.degree | Master | - |
dc.contributor.affiliation | 의과대학 의학과 | - |
dc.date.awarded | 2018-02 | - |
- Appears in Collections:
- Files in This Item:
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.